Raymond James Financial Services Advisors, Inc. Centogene N.V. Transaction History

Raymond James Financial Services Advisors, Inc.

$66.3 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 11, 2021	SELL	$9.02 - $12.93 $108,240 - $155,160	-12,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$10.56 - $13.94 $126,720 - $167,280	12,000 New	12,000 $146,000

Others Institutions Holding CNTG

# of Institutions

Shares Held

2.14M

Call Options Held

Put Options Held

Platinum Investment Management LTD Sydney Australia 2000, C3

1.19M
Shares

$450,718
0.03% of portfolio
Scoggin Management LP New York, NY

532K
Shares

$201,996
0.15% of portfolio
Wells Fargo & Company San Francisco, CA

197K
Shares

$74,917
0.0% of portfolio
Landscape Capital Management, L.L.C.

120K
Shares

$45,562
0.01% of portfolio
Stifel Financial Corp St. Louis, MO

22.5K
Shares

$8,531
0.0% of portfolio

View Full List

About Centogene N.V.

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $10.3M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

More about CNTG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account